Sumatriptan Tablet
Product Images NDC 68071-3350

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Sumatriptan (NDC 68071-3350). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 3350 09 A177)

Label for Sumatriptan 50 mg U-D Tablets by NuCare Pharmaceuticals, Inc. The label includes the NDC 68071-3350-9, product number R1302009PED, and specifies that the product is prescription only. Storage instructions indicate to keep at controlled temperature 59-86 °F and out of reach of children. Manufacturer details include packaging by a site in India.*

FDA Label Image

Figure 1. Estimated Probability Of Achieving Initial Headache Response Within 4 Hours Of Treatment In Pooled Trials 1, 2, And 3a (Sumatriptan Fig1)

Line graph illustrating the estimated probability of response over time in minutes from the initial dose for Sumatriptan at 25 mg, 50 mg, and 100 mg doses, compared to placebo. The vertical axis shows probability percentage, and the horizontal axis represents time up to 240 minutes.*

FDA Label Image

Figure 2. The Estimated Probability Of Patients Taking A Second Dose Of Sumatriptan Tablets Or Other Medication To Treat Migraine Over The 24 Hours Following The Initial Dose Of Study Treatment In Poo (Sumatriptan Fig2)

A line graph showing the estimated probability of headache remission or rescue over time in hours from the initial dose, comparing placebo and Sumatriptan doses of 25 mg, 50 mg, and 100 mg. The graph illustrates increasing remission probabilities across all groups up to 24 hours.*

FDA Label Image

Chemical Structure (Sumatriptan Str)

Chemical structure diagram of Sumatriptan Succinate, showing the atomic arrangement and bonds characteristic of this active ingredient used in the medication Sumatriptan 50 mg oral tablets by NuCare Pharmaceuticals, Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.